Want to track BSLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Basilea Pharmaceutica Ltd (BSLN) Statistics
Valuation metrics
Market Cap 811.67M
Enterprise value 718.13M
Trailing P/E (ttm) 15.38
Forward P/E 12.28
PEG ratio -1.26
Price/Sales (ttm) 3.28
Price/Book (mrq) 4.99
Enterprise Value/Revenue 2.9
Enterprise Value/EBITDA 11.28
Overview
Shares outstanding 12.29M
Float 12.21M
Shares short -
% Held by insiders 0.01%
% Held by institutions 0.3%
Average volume (10 days) 23.81K
Average volume (90 days) 39.84K
Price summary
52-Week low 44.7
52-Week high 70.5
Beta 0.42
50-Day moving average 66.24
200-Day moving average 56.47
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Jun 2013
Ex-Dividend Date 11 Apr 2013
Last split factor 1,039:1,029
Last split Date 13 Mar 2007
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.21%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.18%
Return on equity 0.36%
Income Statement
Revenue (ttm) 232.38M
Revenue per share (ttm) 20
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 87.16M
EBITDA 51.05M
Net income to common (ttm) 40.24M
Diluted EPS (ttm) 4.23
Quarterly earnings growth (yoy) -0.57%
Balance Sheet
Total cash (mrq) 159.8M
Total cash per share (mrq) 14.23
Total debt (mrq) 89.22M
Total Debt/Equity (mrq) 0.51
Current ratio (mrq) 6.6%
Book value per share (mrq) 13.12
Cash Flow
Cash flow statement 62.09M
Levered free cash flow (LFCF) 49.16M
2026 © Marketlog. All Rights Reserved.
